Urinary neopterin: A novel biomarker of disease progression in amyotrophic lateral sclerosis.

Stephanie R ShepheardVassilios KarnarosBeben Benyamin David W Schultz Megan DubowskyJoanne WuuTim ChatawayAndrea MalaspinaMichael BenatarMary-Louise Rogers

Published in: European journal of neurology (2022)

Urinary neopterin holds promise as marker of disease progression in ALS and is worthy of future evaluation for its potential to predict response to anti-inflammatory therapies.

Keyphrases

anti inflammatory
current status
amyotrophic lateral sclerosis
artificial intelligence
clinical evaluation